Gene Hackman death investigation: Doctor claims Betsy 'didn't know how sick she was' in final days
In an exclusive interview with Fox News Digital, Dr. Josiah Child - a physician who oversees Cloudberry Health, the medical practice that Betsy called on Feb. 12 according to preliminary phone records - said the late classical pianist did not initially express symptoms of hantavirus pulmonary syndrome.
"[Betsy] had actually made an appointment to have an initial visit with one of our doctors on the 12th," Dr. Child said. "She called on the 10th saying that her husband was ill or wanted to take care of her husband. She wanted to cancel that appointment. She called back on the 12th and [looking for] advice. She said, 'I have some congestion and I just want some advice. What can I do for it.?' She had no shortness of breath or chest pain or fever or anything like that. Our receptionist spoke to the doctor and the doctor said, 'Well, I've never met her. We have to have an initial appointment.'"
On Monday, the Santa Fe Sheriff's Department confirmed that Betsy's last cell phone activity was Feb. 12, the day after she was initially presumed to have died.
"We can now confirm that Mrs. Hackman's phone was utilized on the morning of February 12 to call a medical center in Santa Fe, Cloudberry Health," the sheriff's department told Fox News Digital. "A total of three calls were made that morning, all to the medical center. One incoming call was made to Mrs. Hackman from the same medical center that afternoon."
According to Dr. Child, the practice scheduled Betsy for a 1 p.m. appointment on Feb. 12 after she called that morning, but she never showed up. The practice then called Betsy, but there was no answer.
"If we had known the patient and known that they had a medical condition or something, then if we try and call them and they didn't call back, we would be more aggressive about finding out what's going on," said Dr. Child. "But in this case, I think, since the doctor had never seen the patient, it was unclear whether maybe she found another doctor or went somewhere else."
"We assumed since she'd never come before that she'd gone somewhere else or maybe to her previous doctor," he added.
Dr. Child said it sounded like Betsy was "starting to feel ill" but was not fully aware of how sick she was actually becoming.
"I don't know whether it was because she was focusing on her husband or because it was a rapidly progressive disease, or she was just one of those people that didn't really feel a lot of discomfort. No one will ever know," he said. "But for some reason she didn't recognize that she was becoming very ill with the second phase of Hantavirus, which invades the lungs."
"She just didn't know how sick she was becoming," he added.
"But for some reason she didn't recognize that she was becoming very ill with the second phase of Hantavirus, which invades the lungs. She just didn't know how sick she was becoming."
Betsy died due to hantavirus pulmonary syndrome, which is transmitted from animals to humans and is commonly found in rodents, the New Mexico Department of Health confirmed.
Hantavirus is characterized by "flu-like symptoms consisting of fever, muscle aches, cough, sometimes vomiting and diarrhea that can progress to shortness of breath and cardiac or heart failure and lung failure," Chief Medical Investigator Dr. Heather Jarrell explained during the news conference.
Hackman died due to hypertensive atherosclerosis cardiovascular disease, with Alzheimer's disease as a significant contributing factor, New Mexico officials confirmed one week ago. He was likely alone in the home for about a week until he died around Feb. 18, which was the last time activity was recorded on his pacemaker.
WATCH: GENE HACKMAN AND WIFE'S CAUSE OF DEATH REVEALED
On Monday, the Hackman estate was awarded a temporary restraining order against the release of records regarding the deaths of Gene and Betsy.
The order stated the "Office of the Medical Investigator and the Santa Fe County Sheriff's Office, including each entities' agents, assigns, and employees are hereby temporarily restrained from disclosing through IPRA or other means, any and all photographs or videos containing images of the following: the body of Gene Hackman, the body of Betsy Arakawa-Hackman, the interior of Mr. and Mrs. Hackman's residence."
Additionally, "any lapel video footage," including the Hackmans' bodies or footage of "images of any deceased animals at the Hackman residence," was added to the temporary restraining order.
The Office of the Medical Investigator was temporarily restrained from disclosing the autopsy and/or death reports, according to the order. A hearing was set for March 31.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Fox News
6 hours ago
- Fox News
We're Micro‑Poisoning Ourselves—Biohacker Slams America's $5T Health Spending
Biohacker Gary Brecka pulls back the curtain on America's health meltdown on Fox News Digital— exposing why trillions in healthcare cash aren't saving us
Medscape
8 hours ago
- Medscape
Rivaroxaban May Improve Outcomes in Cirrhosis
TOPLINE: Rivaroxaban improved portal hypertension-related complication-free survival in patients with cirrhosis and moderate liver dysfunction, without significantly increasing the risk for major bleeding events. METHODOLOGY: Researchers conducted a randomised trial of 90 patients with cirrhosis, portal hypertension, and moderate liver dysfunction (on the basis of the Child-Pugh score) who were enrolled at 14 hospitals in Spain between May 2016 and October 2020 to assess the improvement in outcomes with rivaroxaban. Patients were randomly assigned to receive either 10 mg rivaroxaban daily (n = 41; median age, 58 years; 85.4% men) or matched placebo (n = 49; median age, 59 years; 79.6% men) for up to 24 months. The primary combined endpoint was the time to the first occurrence of any portal hypertension-related complication (including new-onset ascites, portal hypertensive gastrointestinal bleeding, and overt hepatic encephalopathy), death, portal vein thrombosis, hepatocellular carcinoma, or liver transplantation. The safety of rivaroxaban and the incidence of non-portal hypertension-related bleeding events were also assessed. The mean follow-up duration was 10.1 months. TAKEAWAY: The primary combined endpoint occurred in 26.8% of patients in the rivaroxaban group vs 46.9% of those in the placebo group, with 1-year survival probabilities of 78.7% vs 54.4% and 2-year survival probabilities of 67.1% vs 43.0%. The risk of reaching the main endpoint was reduced in the rivaroxaban group (adjusted hazard ratio [HR], 0.418; 95% CI, 0.204-0.858). In a subgroup analysis, a significant effect of rivaroxaban vs placebo was observed in patients with a Child-Pugh B score of 7 points (n = 55; HR, 0.258; 95% CI, 0.074-0.900). The rivaroxaban group experienced bleeding events related to non-portal hypertension more frequently than the placebo group (relative risk, 2.56; 95% CI, 1.16-5.67); no differences in first or recurrent portal hypertension-related bleeding or other adverse events were observed between the two groups. IN PRACTICE: "Unfortunately, there was no clinical or biochemical parameter able to predict rivaroxaban levels obtained after 10 mg rivaroxaban and, if our data on the beneficial effects of rivaroxaban are confirmed, monitoring of rivaroxaban plasma levels would be required to reduce bleeding risk," the authors of the study wrote. SOURCE: This study was led by Ángela Puente, PhD, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital, Santander, Spain. It was published online on July 19, 2025, in the Journal of Hepatology. LIMITATIONS: The trial was underpowered to show statistical significance. The direct effect of rivaroxaban on portal pressure was not assessed. Alcohol consumption was tracked during follow-up visits through direct questioning, without using scales or biochemical markers. DISCLOSURES: This study was supported by grants from Instituto de Salud Carlos III and co-funded by the European Union. Support was also received from "Commissioner for Universities and Research from the Department of Economy and Knowledge" of the "Generalitat de Catalunya." Some authors reported receiving grants from Instituto de Salud Carlos III. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
Fox News
a day ago
- Fox News
Do you really need three meals a day? Experts debate the traditional rule
Breakfast, lunch and dinner have been a staple regimen for diet and nutrition — but is it necessary for overall health? Statistics show that most Americans (64%) consume three meals daily and 28% consume two meals — but some may struggle to hit three meals a day, while others prefer smaller, more frequent meals. Serena Poon, a certified nutritionist and longevity wellness advisor based in Los Angeles, said she considers the concept of three meals a "more cultural convention" than a "biological necessity." "There's no magic in 'three meals a day,'" she told Fox News Digital. "What matters is the quality of your food, the timing of your meals, and how well both align with your unique biology and lifestyle." "A flexible routine, such as two nourishing meals and a snack, or three well-balanced meals eaten within a 10- to 12-hour window, has strong scientific backing and fits comfortably into most modern schedules." A 2024 review published in JAMA found that lower meal frequency, earlier calorie distribution and time-restricted eating led to greater weight loss and metabolic improvements than the traditional three-meal pattern, Poon pointed out. "From a nutrition and metabolism perspective, what you eat matters more than when you eat." In another study published this year in Nature Medicine, overweight or obese adults who ate only during an eight-hour window "reduced visceral fat and cardiometabolic risk" just as effectively as standard eating. Extremely low frequencies of eating, such as one meal a day, can "heighten hunger and risk micronutrient gaps, so they require professional guidance," Poon warned. Lauri Wright, PhD, RDN, director of nutrition programs and associate professor at the USF College of Public Health, agreed that the idea of eating three meals a day is cultural, evolving largely from social norms, work schedules and industrialization rather than scientific evidence. "From a nutrition and metabolism perspective, what you eat matters more than when you eat for most people," she said. "Some individuals thrive on three balanced meals a day, while others do well with smaller, more frequent meals. What's important is meeting your body's nutritional needs across the day." Regular meals can help stabilize blood sugar, support energy levels and prevent overeating, especially for those who have conditions like diabetes or are prone to "energy crashes," Wright noted. "But there's no one-size-fits-all pattern," she said. "Skipping breakfast or consolidating meals, for example, can work for some people without negative health effects, as long as nutrient quality and total intake are adequate." "In short, three meals a day can be a helpful guideline, but it's not a strict requirement for health." Poon suggested that "personalization is key" when it comes to eating frequency, but most healthy adults thrive on an eight- to-12-hour eating window that begins within two hours of waking and ends at least three hours before bedtime. She also pointed to study data showing that eating within a 10-hour window for eight weeks improved appetite regulation, sleep quality and morning GLP-1 levels in young adults. People who rise early in the day may benefit from "front-loading" calories into breakfast and lunch, Poon suggested, while shift workers may function better with a later window. Those with conditions such as diabetes, eating disorder histories or pregnancy should ask their doctor about individualized diet plans. "Consider lifestyle, medical needs (like diabetes), age and preferences," Poon advised. "Some thrive on three meals, others on intermittent fasting or grazing — it's about consistency, nutrient quality and listening to your body." The expert also recommended paying attention to internal signals and hunger cues, like gentle stomach rumbling, a dip in focus or mild irritability. A meal should end at "comfortable satiety," or a feeling of satisfaction. "Intuitive eating practices have been linked to lower morning cortisol, better mental health and sleep scores, and improved mood metrics," she said. Instead of eating based on the clock, listening to authentic hunger and fullness cues will help maintain steady energy, sharpen focus and avoid last-minute, less-nutritious choices, Poon added. For more Health articles, visit "Whatever cadence you choose, keep the focus on whole foods, balanced macronutrients and nutrient-rich options," she recommended. "Most importantly, stay consistent in a pattern that honors your circadian rhythm, accommodates your social life and supports your personal health goals."
